CIK 0001703647
- Non-accelerated filer
- Smaller reporting company
Korro Bio, Inc.
Sign in to watch- Ticker
- KRRO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472324450
- Phone
- +1 617-468-1999
- Business address
- 60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
- Former names
- Frequency Therapeutics, Inc.
- Open-market buys, last 90 days
- $884,752
- in 1 filing
- Open-market sales, last 90 days
- $1,763,410
- in 5 filings, $1.8M under 10b5-1 plans
Net −$878,658. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 5 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-17 | Lucchino David L. President and CEO | Exercise or conversion · Stock Option | −1,120 | 288,910 | ||
| 2020-12-17 | Loose Christopher R. Chief Scientific Officer | Sale | −6,000 | $40.00 | $240K | 41,782 |
| 2020-12-17 | Loose Christopher R. Chief Scientific Officer | Sale | −2,000 | $42.50 | $85K | 39,782 |
| 2020-12-16 | Lucchino David L. President and CEO | Exercise or conversion | +13,514 | $0.61 | $8K | 337,314 |
| 2020-12-16 | Lucchino David L. President and CEO | Sale | −13,514 | $40.00 | $541K | 323,800 |
| 2020-12-16 | Lucchino David L. President and CEO | Exercise or conversion · Stock Option | −13,514 | 290,030 | ||
| 2020-12-16 | Loose Christopher R. Chief Scientific Officer | Sale | −4,000 | $37.87 | $151K | 51,782 |
| 2020-12-16 | Loose Christopher R. Chief Scientific Officer | Sale | −4,000 | $40.00 | $160K | 47,782 |
| 2020-12-15 | Lucchino David L. President and CEO | Exercise or conversion | +6,411 | $0.61 | $4K | 330,211 |
| 2020-12-15 | Lucchino David L. President and CEO | Exercise or conversion | +7,103 | $0.61 | $4K | 337,314 |
| 2020-12-15 | Lucchino David L. President and CEO | Sale | −9,014 | $38.18 | $344K | 328,300 |
| 2020-12-15 | Lucchino David L. President and CEO | Sale | −4,500 | $38.83 | $175K | 323,800 |
| 2020-12-15 | Lucchino David L. President and CEO | Exercise or conversion · Stock Option | −6,411 | 3,913 | ||
| 2020-12-15 | Lucchino David L. President and CEO | Exercise or conversion · Stock Option | −7,103 | 303,544 | ||
| 2020-12-15 | Loose Christopher R. Chief Scientific Officer | Sale | −8,000 | $37.28 | $298K | 55,782 |
| 2020-12-14 | Lucchino David L. President and CEO | Exercise or conversion | +13,514 | $0.61 | $8K | 337,314 |
| 2020-12-14 | Lucchino David L. President and CEO | Sale | −13,514 | $35.12 | $475K | 323,800 |
| 2020-12-14 | Lucchino David L. President and CEO | Exercise or conversion · Stock Option | −13,514 | 10,324 | ||
| 2020-12-14 | Loose Christopher R. Chief Scientific Officer | Sale | −8,000 | $35.00 | $280K | 63,782 |
| 2020-12-09 | Lucchino David L. President and CEO | Exercise or conversion | +13,514 | $0.61 | $8K | 337,314 |
Page 27 of 34 · 670 trades